MAGEC1 and AL amyloidosis: We recently investigated expression of MAGE-C1/CT7 in myeloma plasma cells from bone-marrow lesions of multiple myeloma patients and described that the sub-cellular localization of MAGE-C1/CT7 (nucleus or cytoplasm) has prognostic value such that combined nuclear and cytoplasmic expression correlates with reduced survival [27].